AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
BEVACIZUMAB in Kenya
5 products registered with PPB — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AVASTIN 400MG Concentrate For Solution For Infusion | H2008/17090B/R1 | F. HOFFMAN-LA ROCHE LTD | active | 21 Apr 2031 |
| AVASTIN 100MG Concentrate For Solution For Infusion | H2005/308/17090/R1 | F. HOFFMAN-LA ROCHE LTD | active | 21 Apr 2031 |
| BEVAMAB 100 Infusion | H2026/CTD11020/23313 | INTAS PHARMACEUTICALS LIMITED | active | 14 Mar 2031 |
| PERSIVIA Concentrate For Solution For Infusion | H2025/CTD12389/27067 | DR. REDDY’S LABORATORIES LIMITED | active | 7 Mar 2030 |
| BEVAMAB 400 Injection | H2022/CTD8114/16003 | INTAS PHARMACEUTICALS LTD | active | 5 Apr 2027 |
BEVACIZUMAB — PPB Registration Details
PPB (Kenya) has 5 registered products containing BEVACIZUMAB, of which 5 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track BEVACIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.